Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
Kanghui Yang, Jinghong Fen, Hao Fang, Lei Zhang, Jianzhi Gong, Wenfang Xu
Index: J. Enzyme Inhib. Med. Chem. 27(2) , 302-10, (2012)
Full Text: HTML
Abstract
A series of novel L-isoserine derivatives were synthesised and evaluated for their ability to inhibit aminopeptidase N (APN)/CD13. In our preliminary biological results, some of these compounds possessed a potent inhibitory activity against the APN. Within this series, compound 14b not only showed similar enzyme inhibition (IC₅₀ of 12.2 μM) compared with the positive control bestatin (half maximal inhibitory concentration (IC₅₀) of 7.3 μM), but also had a potent antiproliferative activity against human cancer cell lines cells.
Related Compounds
Related Articles:
2005-09-05
[Eur. J. Pharmacol. 519(1-2) , 43-7, (2005)]
2006-12-01
[ChemBioChem. 7(12) , 1982-9, (2006)]
2001-05-01
[Biosci. Biotechnol. Biochem. 65(5) , 1258-60, (2001)]
2010-01-01
[Bioorg. Med. Chem. 18(1) , 19-27, (2010)]
2005-04-01
[J. Org. Chem. 70(7) , 2439-44, (2005)]